How to Prevent Wrong Strength or Wrong Market Artwork Errors


Published on 04/05/2026

Strategies for Avoiding Errors in Strength or Market Artwork in Pharmaceuticals

In the fast-paced world of pharmaceutical manufacturing, errors in artwork strength or market representation can have significant repercussions, impacting compliance, patient safety, and brand integrity. This article provides step-by-step guidance aimed at professionals in manufacturing, quality control (QC), quality assurance (QA), and engineering roles, enabling teams to effectively recognize, contain, investigate, and prevent such errors.

By following the outlined methodologies, you’ll be equipped to establish a robust framework for artwork control and regulatory review, mitigating the risk associated with discrepancies in pharmaceutical packaging. This systematic approach not only addresses immediate issues but also fortifies long-term quality systems.

1. Symptoms/Signals on the Floor or in the Lab

Identifying the early symptoms of artwork errors is crucial for rapid containment and investigation. Here are some common signals to watch for:

  • Discrepancies in Product Labeling: Mismatched product names, strengths, or indications compared to submission files or specifications.
  • Approval Delays: Uncharacteristic hold-ups in artwork approvals due to internal or external feedback.
  • Customer Complaints: Reports of mislabeling or product strength discrepancies from marketing
or directly from consumers.
  • Increased Deviations: A spike in deviations related to packaging material or labeling.
  • Audit Findings: Regulatory inspection reports that highlight concerns related to labeling compliance and records.
  • 2. Likely Causes

    Understanding the causes of errors can help in formulating effective corrective and preventive measures. Categorizing potential failures can clarify which area needs intervention:

    Category Likely Causes
    Materials Incorrect or outdated versions of artwork being used, unapproved changes to packaging materials.
    Method Inadequate or poorly defined procedures for artwork review and approval.
    Machine Issues with printing technologies that may cause errors in the final product.
    Man Human error during data entry or approval processes.
    Measurement Failure to properly audit or validate data related to artwork submissions.
    Environment Poor communication or lack of collaboration between departments (QA, manufacturing, marketing).

    3. Immediate Containment Actions (First 60 Minutes)

    In the event artwork errors are detected, prompt immediate containment is necessary to mitigate the impact. Execute the following actions within the first hour:

    1. Stop Production: Cease any ongoing operations that may involve the erroneous artwork to prevent further distribution.
    2. Inform Affected Stakeholders: Notify all relevant departments – manufacturing, QA, regulatory, and marketing regarding the potential error.
    3. Quarantine Products: Identify and segregate affected products or materials that have been tagged with the incorrect artwork.
    4. Review Documentation: Gather all relevant documentation that pertains to artwork changes, approvals, and production records.
    5. Assess Potential Impact: Evaluate the extent of the impact on current inventories and determine if batch recalls or corrections are necessary.

    4. Investigation Workflow (Data to Collect + How to Interpret)

    A structured investigation workflow is essential to uncover the root causes of artwork errors. The following data should be collected:

    • Artwork Submissions: Obtain all documents related to the submitted artwork, including previous versions, approvals, and any notes on revisions.
    • Change Control Records: Gather records detailing any changes made to the artwork before it was produced.
    • Production Logs: Compile records from the manufacturing floor that detail when and how the artwork was used.
    • Quality Review Reports: Collect reports from QA regarding the evaluation of artwork, including any observations made during previous audits.
    • Communication Records: Review emails and internal communications regarding artwork changes or issues.

    Once the data is collected, interpret it by identifying patterns or trends that may indicate persistent issues or singular events that resulted in the error.

    5. Root Cause Tools

    Employing appropriate root cause analysis tools facilitates a deeper understanding of why the error occurred. Here are three tools and their ideal applications:

    • 5-Why Analysis: Use this method when a clear issue has been identified. Asking ‘Why’ multiple times (typically five) can help drill down to the root cause.
    • Fishbone Diagram (Ishikawa): Effective for visualizing multiple potential causes categorized under various factors (Man, Method, Machine, etc.). Utilize during brainstorming sessions.
    • Fault Tree Analysis: Implement when complex systems contribute to the issue. This method demonstrates the logical relationship between faults and helps in identifying contributing factors.

    6. CAPA Strategy

    Corrective Action and Preventive Action (CAPA) strategies should address both the immediate issues identified and the underlying causes to prevent recurrence.

    1. Correction: Implement immediate fixes to rectify the issue. This may involve updating incorrect artwork and re-printing affected materials.
    2. Corrective Action: Establish actions based on the root cause findings to eliminate causes of the artwork discrepancies. This may include revisions to artwork review protocols.
    3. Preventive Action: Develop long-term preventive measures by identifying potential risks in the artwork approval workflow and implementing training sessions for all critical personnel.

    7. Control Strategy & Monitoring

    To ensure ongoing compliance and performance reliability in artwork control, develop a comprehensive control strategy. Key elements include:

    Related Reads

    • Statistical Process Control (SPC): Utilize SPC charts to monitor variations in artwork errors and production-related data.
    • Sampling Techniques: Establish regular sampling of printed materials against approved artwork for quality checks prior to mass distribution.
    • Alarms and Alerts: Set up thresholds for triggering alerts if deviations from established norms occur.
    • Verification Procedures: Conduct periodic verification of the processes for effectiveness, ensuring they align with regulatory compliance requirements.

    8. Validation / Re-qualification / Change Control Impact

    When errors occur, it may necessitate a re-evaluation of related validation activities, particularly if affected products are already in circulation.

    • Validation Impact: Determine if the overall validation documentation and processes for affected products are still adequate and if they require updates.
    • Re-qualification: If changes in artwork require updates to manufacturing equipment or processes, ensure rigorous re-qualification follows validation protocols.
    • Change Control Review: Discuss whether the artwork control management process needs modification in the change control system to prevent similar incidents in the future.

    9. Inspection Readiness: What Evidence to Show

    Being inspection-ready involves maintaining comprehensive records to support compliance with regulatory bodies such as the FDA, EMA, and MHRA. Important documents include:

    • Records and Logs: Maintain detailed logs of all changes made, including artwork approval documentation and revision histories.
    • Batch Documents: Ensure that all batch records reflect accurate and approved artwork.
    • Deviation Reports: File records of any deviations related to artwork discrepancies and associated CAPA measures.

    FAQs

    What is the first step to take if I notice a packaging error?

    Immediately halt production and notify all relevant stakeholders to prevent further errors in distribution.

    How do I systematically investigate the cause of a packaging error?

    Collect relevant documentation, review processes, and apply root cause analysis tools such as the 5-Why or Fishbone Diagram.

    How can I prevent future errors related to artwork?

    Focus on strengthening the artwork review procedures, enhancing staff training, and implementing robust CAPA strategies.

    What documentation is required for inspection readiness?

    Maintain all change control records, batch documents, deviation reports, and any communications related to the artwork.

    When should I update my validation protocols?

    Validation should be reviewed and potentially updated whenever there are significant changes to the artwork, processes, or materials used.

    Are there specific regulations guiding artwork control?

    Yes, regulatory bodies like the FDA and EMA have laid down stringent requirements regarding labeling and artwork compliance.

    How often should artwork be reviewed?

    Regular reviews should be scheduled as part of routine quality checks, with additional reviews prompted by changes in market requirements or internal processes.

    What role does training play in artwork control?

    Training ensures that all personnel are aware of the processes and pitfalls associated with artwork production, reducing the chance of human error.

    Pharma Tip:  Artwork Control for Cold Chain and Specialty Medicines